Address: Not specified
Projects: SysMO DB, FAIRDOM, ICYSB 2015 - International Practical Course in Systems Biology, ZucAt, SysMO-LAB, Kinetics on the move - Workshop 2016, Training material, FAIRDOM user meeting, ErasysApp Funders, MycoSynVac - Engineering Mycoplasma pneumoniae as a broad-spectrum animal vaccine, EmPowerPutida
I am a researcher at the Scientific Databases and Visualization Group at Heidelberg Institute for Theoretical Studies (HITS) , one of the developers of SabioRK - System for the Analysis of Biochemical Pathways - Reaction Kinetics (http://sabiork.h-its.org/) . I am working on design and maintenance of the information systems to store, query and analyse systems biology data; definition and implementation of methods for the integration of data from multiple sources. In SySMO-DB project
Disciplines: Not specified
Roles: Not specified
Expertise: Not specified
Tools: Not specified
I finished my biotechnology studies at Pablo de Olavide University (Seville) in 2010 and after that got a master degree in microbiology (Granada University). During my PhD (2010-2014) at Estación Experimental del Zaidín (Granada, Spain), I focused on the study of the biosynthesis of antibiotic compounds and the signaling mechanisms underlying antibiotic resistance in Pseudomonas putida from a transcriptomic and molecular point of view.
Exploiting native endowments by re-factoring, re-programming and implementing novel control loops in Pseudomonas putida for bespoke biocatalysis. The EmPowerPutida project aims to engineer the lifestyle of Pseudomonas putida to generate a tailored, re-factored chassis for the production of so far non-accessible biological compounds. Pseudomonas putida is a bacterium with a highly versatile metabolism, including the capability to degrade or produce organic chemicals.
The MycoSynVac project AIMS at using cutting-edge synthetic biology methodologies to engineer Mycoplasma pneumoniae as a universal chassis for vaccination.
Designing a universal Mycoplasma chassis that can be deployed as single- or multi-vaccine in a range of animal hosts. Annually, infections caused by Mycoplasma species in poultry, cows, and pigs result in multimillion Euro losses in the USA and Europe.
There is no effective vaccination against many Mycoplasmas that infect pets, humans and farm